Product Images Potassium Chloride

Each extended-release tablet of NDC 60219-1065-1 contains 750 mg of potassium chloride, USP, which is equivalent to 10 mEq of potassium. Dosage must be individualized for each patient. Refer to the accompanying package insert for full prescribing information and visual dosage. Store the tablets at 20° to 25°C (68° to 77°F) and keep them tightly closed in a tight, light-resistant container as defined in the USP. Excursions between 15° to 30°C (50° to 86°F) are permitted. Amneal Pharmaceuticals Ltd. manufactures the tablets in Ahmedabad, India, and Amneal Pharmaceuticals LLC distributes them in Bridgewater, NJ. The FDA's approved criteria for assay may differ from the USP test. Keep the tablets out of children's reach.*

Each tablet of this medication (NDC 60219-1065-7) contains 750mg of potassium chloride, which is equivalent to 10 milliequivalents of potassium. The dosage of the extended-release medication should be customized according to the individual needs of each patient, and the full prescribing information is available in the package insert. The tablets should be stored at a temperature between 20 to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The medication must be kept tightly closed and in a tight, light-resistant container, out of reach of children. The FDA approved assay criteria for this medication are different from the USP test. The medication is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

This is a description of Potassium Chloride Extended-Release Tablets, USP with a strength of 1,500 mg/tablet (equivalent to 20 mEq of potassium). The dosage must be tailored to individual needs, and storage must be at 20-25°C (68-77°F) with tight closure and protection from light. The tablets should be dispensed in a tight, light-resistant container and kept out of the reach of children. These tablets are manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The FDA has approved these tablets with different acceptance criteria for assay compared to the USP test.*

This is a potassium chloride extended-release tablet. Each tablet contains 1,500 mg of potassium chloride (equivalent to 20 mEq of potassium) and must be adjusted according to the individual needs of each patient. The recommended dosage is included in the package insert. The tablets should be stored at room temperature and in a tightly closed container. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd, located in Ahmedabad, India, and the product is distributed by Amneal Pharmaceuticals LLC located in Bridgewater, NJ.*